Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
ConclusionsAbnormal liver biochemical tests are common in COVID-19 patients. Liver biochemical indicators are closely related to the severity and prognosis of COVID-19 patients.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Bilirubin | China Health | COVID-19 | Databases & Libraries | Infectious Diseases | Liver | Pandemics | Study | Urology & Nephrology